FDA approves twice yearly injection for treatment for adults with schizophrenia Hina Zahid3 Sept 2021 10:15 AM ISTUSA: The U.S. Food and Drug Administration (FDA) has approved Invega Hafyera (paliperidone palmitate), the first-and-only twice-yearly injectable for...
FDA approves novel rehabilitation system for stroke victims Dr Kartikeya Kohli28 Aug 2021 9:15 AM ISTThe U.S. Food and Drug Administration has approved first-of-its-kind, drug-free rehabilitation system intended to treat moderate to severe upper...
FDA approves drug for chronic, excessive sleepiness during daytime Dr. Kamal Kant Kohli13 Aug 2021 8:15 AM ISTThe US Food and Drug Administration has approved a new indication for Xywav for idiopathic hypersomnia (IH) in adults. Xywav (calcium, magnesium,...
Alzheimer's drug Aduhelm receives FDA's accelerated approval Hina Zahid8 Jun 2021 10:32 AM ISTUSA: Aduhelm (aducanumab) has received the US FDA's accelerated approval for the treatment of Alzheimer's disease. Aduhelm was approved using...
Diagnostic device for autism receives FDA's marketing authorization Hina Zahid3 Jun 2021 11:33 AM ISTMarketing authorization provides a new tool for helping diagnose children with ASD.USA: The US Food and Drug Administration has approved marketing...
Myfembree receives FDA approval for uterine fibroids associated heavy menstrual bleeding Hina Zahid29 May 2021 7:15 AM ISTUSA: The Food and Drug Administration (FDA) has approved Myfembree, a once-a-day therapy for managing heavy menstrual bleeding associated with...
FDA says no to COVID-19 Antibody Tests to Assess Immunity After Vaccination MD Bureau27 May 2021 9:30 AM ISTThe US Food and Drug Administration (FDA) issued a safety communication reminding the public and healthcare providers that results from currently...
FDA approves Empaveli for treatment of paroxysmal nocturnal hemoglobinuria Medha Baranwal18 May 2021 3:15 PM ISTUSA: The US Food and Drug Administration has approved Apellis' Empaveli (pegcetacoplan) injection for the treatment of paroxysmal nocturnal...
FDA fast tracks novel drug for reducing adhesions after abdominal surgery Medha Baranwal17 May 2021 10:00 AM ISTUSA: The U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to the Palisade Bio's investigational drug LB1148 for the...
FDA approves Zynrelef for managing postoperative pain up to 72 hours Medha Baranwal15 May 2021 7:14 AM ISTUSA: The US Food and Drug Administration (FDA) has given its approval to Heron Therapeutics' Zynrelef (bupivacaine and meloxicam) for the treatment of...
Device for smart insulin management receives FDA clearance Medha Baranwal13 May 2021 11:00 AM ISTUSA: A system that can help in improve insulin dosing in patients with either type 1 or type 2 diabetes has received US FDA's 510(k) clearance.The...
US FDA clears marketing of device for rehabilitation of stroke patients Medha Baranwal26 April 2021 2:30 PM ISTUSA: The US Food and Drug Administration has authorized the marketing of a new device that assists in rehabilitation for stroke patients with upper...
